Biotech Values

[cooldrinkh2o]

Agree.........I find it interesting that Roche has yet to make public the durability of response for all the responders in that trial. If the responses were durable, then I think the FDA would be hard pressed to RTF (unless there was a high percentage of missing scans or some other data management issues).